These guidelines outline recommendations for the management of patients with AL amyloidosis, including treatment, monitoring and how to measure response.
These guidelines, written by the UK Myeloma Forum in conjunction with the Nordic Myeloma Study Group provide guidance for the effective clinical investigation of patients with newly detected paraprotein and the practical management of patients with monoclonal gammopathy of undetermined significance (MGUS).
In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.
This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.